In early October 2025, Intellia Therapeutics presented new clinical results at the European Society of Gene & Cell Therapy Congress, highlighting long-term safety and efficacy data for its ...
Acquisition adds potential first- and best-in-class asset, enhancing Novo Nordisk’s portfolio for treatment of MASH, one of the most prevalent obesity related comorbidities Akero Therapeutics’s FGF21 ...
The U.S. Space Force has selected SpaceX and United Launch Alliance to perform the first seven launches under the National Security Space Launch Program, or NSSL, Phase 3 Lane 2 contracts, Breaking ...
EDISTO ISLAND — The State Law Enforcement Division is investigating a fire that started the morning of Oct. 4 at Circuit Court Judge Diane Goodstein's Edisto Beach home off Planters Retreat in the ...
Rechargeable batteries are the primary components in EVs, mobile devices, and energy storage systems. The batteries’ working conditions, including state of health (SOH), state of charge (SOC), and ...
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide, an investigational cereblon E3 ligase modulator (CELMoD™ ...
Preseason action so far for the Kings isn’t just about preparing for the 2025-26 season, but it’s a chance to evaluate which young players are ready to take the next step moving forward into the ...
AtlasClear Holdings Inc. (NYSE:ATCH) shares are trending on Thursday. Check out the current price of ATCH stock here. ATCH experienced explosive pre-market trading, jumping 15.43% to $1.87 per share ...
Regeneron is racing to regulators after reporting a phase 3 win in an ultrarare disease. The biotech plans to file for FDA approval of garetosmab in fibrodysplasia ossificans progressiva (FOP) by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback